The idea behind the TRUSB stems from a growing recognition of the critical role that patients and clinicians play in healthcare innovation.

Their lived experience and professional expertise are key to making research patient-focused and ensuring technological solutions are attuned to real-world needs.

This collaborative effort aligns with the European Union’s emphasis on patient involvement in health research as a prerequisite for funding, reflecting a broader shift towards patient empowerment in healthcare decision-making.

The TRUSB will be split into two subgroups: TRUSB-P for patients and TRUSB-C for clinicians, each bringing invaluable insights to the development of a state-of-the-art AI monitoring tool.

Integrated by individuals with lived experience of psychosis and clinicians specialising in its treatment, the TRUSB is tasked with guiding the project’s direction, ensuring that the AI tool developed is trustworthy, and user-friendly. They will work alongside researchers, contributing to the design of a Random Clinical Trial (RCT), shaping strategic communications, and assisting in the development of an educational course.

As the project progresses, the TRUSB will continue to play a crucial role in bridging the gap between technological innovation and practical application, ensuring the development of tools that are not only effective but also deeply resonant with the needs of those they are designed to help.